Truist Securities Maintains Hold Rating for Aveanna Healthcare Hldgs: Here's What You Need To Know

Truist Securities has decided to maintain its Hold rating of Aveanna Healthcare Hldgs AVAH and raise its price target from $1.40 to $1.70.

Shares of Aveanna Healthcare Hldgs are trading up 5.88% over the last 24 hours, at $1.62 per share.

A move to $1.70 would account for a 4.94% increase from the current share price.

About Aveanna Healthcare Hldgs

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. HHH segment provides home health, hospice, and specialty program services to elderly populations seeking compassionate care and assistance with activities of daily living in the home. MS segment provides needed supplies to patients requiring enteral nutrition services or respiratory care.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.